Recent Quotes (30 days)

You have no recent quotes
chg | %

Hercules Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
-0.03 (-0.22%)
Real-time:   10:54AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 13.18 - 13.25
52 week 11.85 - 15.68
Open 13.22
Vol / Avg. 99,134.00/937,133.00
Mkt cap 1.09B
P/E 20.66
Div/yield 0.31/9.39
EPS 0.64
Shares 82.78M
Beta 0.86
Inst. own 46%
Aug 2, 2017
Q2 2017 Hercules Capital Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 7, 2017
Hercules Capital Inc Annual Shareholders Meeting (Estimated) - 12:00PM EDT - Add to calendar
Jun 22, 2017
Hercules Capital Inc at JMP Securities Financial Services and Real Estate Conference Add to calendar
May 4, 2017
Q1 2017 Hercules Capital Inc Earnings Call - Webcast
May 4, 2017
Q1 2017 Hercules Capital Inc Earnings Release
Mar 27, 2017
Hercules Capital Inc at Sachs Associates Neuroscience BioPartnering & Investment Forum
Mar 8, 2017
Hercules Capital Inc at RBC Capital Markets Financial Institutions Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin -12.05% 39.25%
Operating margin 48.91% 52.75%
EBITD margin - 55.62%
Return on average assets -1.47% 4.93%
Return on average equity -2.90% 8.96%
Employees 64 -
CDP Score - -


400 Hamilton Ave Ste 310
PALO ALTO, CA 94301-1805
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology industries. The Company's investment objective is to maximize its portfolio total return by generating current income from its debt investments and capital appreciation from its warrant and equity-related investments. The Company's primary business objectives are to increase its net income, net operating income and net asset value (NAV) by investing in structured debt with warrants and equity of venture capital-backed companies in technology-related industries with attractive current yields and the potential for equity appreciation and realized gains. The Company focuses its investments in companies active in the technology industry sub-sectors.

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark Robert Harris CPA Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Scott Bluestein Chief Investment Officer
Age: 36
Bio & Compensation  - Reuters
Melanie Grace Chief Compliance Officer, General Counsel
Age: 46
Bio & Compensation  - Reuters
Andrew Olson Vice President - Finance, Senior Controller
Age: 32
Bio & Compensation  - Reuters
Jennifer McKay Vice President of Human Resources
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
Doreen Woo Ho Director
Age: 69
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 62
Bio & Compensation  - Reuters
Thomas J. Fallon Independent Director
Age: 55
Bio & Compensation  - Reuters